These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26980146)

  • 1. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
    Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
    Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different
    Chin YT; He ZR; Chen CL; Chu HC; Ho Y; Su PY; Yang YSH; Wang K; Shih YJ; Chen YR; Pedersen JZ; Incerpi S; Nana AW; Tang HY; Lin HY; Mousa SA; Davis PJ; Whang-Peng J
    Front Endocrinol (Lausanne); 2019; 10():130. PubMed ID: 30915033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
    Huang TY; Chang TC; Chin YT; Pan YS; Chang WJ; Liu FC; Hastuti ED; Chiu SJ; Wang SH; Changou CA; Li ZL; Chen YR; Chu HR; Shih YJ; Cheng RH; Wu A; Lin HY; Wang K; Whang-Peng J; Mousa SA; Davis PJ
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
    Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
    Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.
    Chang TC; Chin YT; Nana AW; Wang SH; Liao YM; Chen YR; Shih YJ; Changou CA; Yang YS; Wang K; Whang-Peng J; Wang LS; Stain SC; Shih A; Lin HY; Wu CH; Davis PJ
    Horm Cancer; 2018 Dec; 9(6):420-432. PubMed ID: 30187356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer.
    Lee YS; Chin YT; Shih YJ; Nana AW; Chen YR; Wu HC; Yang YSH; Lin HY; Davis PJ
    Horm Cancer; 2018 Jun; 9(3):156-165. PubMed ID: 29380230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
    Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
    Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.
    Nana AW; Wu SY; Yang YS; Chin YT; Cheng TM; Ho Y; Li WS; Liao YM; Chen YR; Shih YJ; Liu YR; Pedersen J; Incerpi S; Hercbergs A; Liu LF; Whang-Peng J; Davis PJ; Lin HY
    Horm Cancer; 2018 Oct; 9(5):349-360. PubMed ID: 30027502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
    Lin HY; Landersdorfer CB; London D; Meng R; Lim CU; Lin C; Lin S; Tang HY; Brown D; Van Scoy B; Kulawy R; Queimado L; Drusano GL; Louie A; Davis FB; Mousa SA; Davis PJ
    PLoS Comput Biol; 2011 Feb; 7(2):e1001073. PubMed ID: 21304935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.
    Yang YSH; Ko PJ; Pan YS; Lin HY; Whang-Peng J; Davis PJ; Wang K
    J Biomed Sci; 2021 Apr; 28(1):24. PubMed ID: 33827580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
    Davis PJ; Lin HY; Hercbergs A; Mousa SA
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
    Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
    Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
    Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
    Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
    Lin SJ; Chin YT; Ho Y; Chou SY; Sh Yang YC; Nana AW; Su KW; Lim YT; Wang K; Lee SY; Shih YJ; Chen YR; Whang-Peng J; Davis PJ; Lin HY; Fu E
    Food Chem Toxicol; 2018 Oct; 120():1-11. PubMed ID: 29960019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
    Nana AW; Chin YT; Lin CY; Ho Y; Bennett JA; Shih YJ; Chen YR; Changou CA; Pedersen JZ; Incerpi S; Liu LF; Whang-Peng J; Fu E; Li WS; Mousa SA; Lin HY; Davis PJ
    Endocr Relat Cancer; 2018 Mar; 25(3):279-293. PubMed ID: 29255096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
    Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.
    Unson S; Chang TC; Yang YN; Wang SH; Huang CH; Crawford DR; Huang HM; Li ZL; Lin HY; Whang-Peng J; Wang K; Davis PJ; Li WS
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc.
    Yu Y; Guo M; Wei Y; Yu S; Li H; Wang Y; Xu X; Cui Y; Tian J; Liang L; Peng K; Liu T
    Oncotarget; 2016 Dec; 7(49):80888-80900. PubMed ID: 27825133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
    Huang CH; Huang TY; Chang WJ; Pan YS; Chu HR; Li ZL; Unson S; Chin YT; Lin CY; Huang HM; Hsiung CN; Gionfra F; De Vito P; Pedersen JZ; Incerpi S; Chen YR; Lee SY; Lin HY; Davis PJ; Whang-Peng J; Wang K
    Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32630719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
    Glinskii AB; Glinsky GV; Lin HY; Tang HY; Sun M; Davis FB; Luidens MK; Mousa SA; Hercbergs AH; Davis PJ
    Cell Cycle; 2009 Nov; 8(21):3562-70. PubMed ID: 19838061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.